1.6K
Articles
47.8K
Citations
3.2
avg. Impact Factor
92
h-index

Most Cited Articles of Department of Oncology in 2012

TitleJournalYearCitations
DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implicationsBlood2012180
Helicobacter pylori eradication therapy is effective in the treatment of early-stage H pylori-positive gastric diffuse large B-cell lymphomasBlood2012101
Estrogen receptor α represses transcription of HBV genes via interaction with hepatocyte nuclear factor 4αGastroenterology201285
Functional dissection of lysine deacetylases reveals that HDAC1 and p300 regulate AMPKNature201280
Volumetric modulated arc therapy for nasopharyngeal carcinoma: a dosimetric comparison with TomoTherapy and step-and-shoot IMRTRadiotherapy and Oncology201277
EML4-ALK translocation predicts better outcome in lung adenocarcinoma patients with wild-type EGFRJournal of Thoracic Oncology201276
Vandetanib in patients with inoperable hepatocellular carcinoma: a phase II, randomized, double-blind, placebo-controlled studyJournal of Hepatology201275
Role of DNA-dependent protein kinase catalytic subunit in cancer development and treatmentTranslational Cancer Research201271
Effects of NFKB1 and NFKBIA gene polymorphisms on susceptibility to environmental factors and the clinicopathologic development of oral cancerPLoS ONE201250
CIP2A-mediated Akt activation plays a role in bortezomib-induced apoptosis in head and neck squamous cell carcinoma cellsOral Oncology201249
Functional characterization of glycine N-methyltransferase and its interactive protein DEPDC6/DEPTOR in hepatocellular carcinomaMolecular Medicine201248
DAB2IP regulates autophagy in prostate cancer in response to combined treatment of radiation and a DNA-PKcs inhibitorNeoplasia201246
Tumor-associated carbonic anhydrase XII is linked to the growth of primary oral squamous cell carcinoma and its poor prognosisOral Oncology201245
Inhibition of Bcl-2 improves effect of LCL161, a SMAC mimetic, in hepatocellular carcinoma cellsBiochemical Pharmacology201242
Dynamic contrast-enhanced MRI in advanced nonsmall-cell lung cancer patients treated with first-line bevacizumab, gemcitabine, and cisplatinJournal of Magnetic Resonance Imaging201242
MMP-9 from sublethally irradiated tumor promotes Lewis lung carcinoma cell invasiveness and pulmonary metastasisOncogene201241
The emerging epidemic of estrogen-related cancers in young women in a developing Asian countryInternational Journal of Cancer201237
Serum insulin-like growth factor-1 levels predict outcomes of patients with advanced hepatocellular carcinoma receiving antiangiogenic therapyClinical Cancer Research201237
Comparison of weekly versus every 3 weeks paclitaxel in the treatment of advanced solid tumors: a meta-analysisCancer Treatment Reviews201236
SOX4 transcriptionally regulates multiple SEMA3/plexin family members and promotes tumor growth in pancreatic cancerPLoS ONE201236
The impact of diabetes mellitus on prognosis of early breast cancer in AsiaOncologist201235
Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3Biochemical Pharmacology201234
Pemetrexed in combination with cisplatin versus cisplatin monotherapy in patients with recurrent or metastatic head and neck cancer: final results of a randomized, double-blind, placebo-controlled, phase 3 studyCancer201234
Role of lipocalin 2 and its complex with matrix metalloproteinase-9 in oral cancerOral Diseases201230
KRAS mutation is a predictor of oxaliplatin sensitivity in colon cancer cellsPLoS ONE201230